Stay updated on AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.

Latest updates to the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedStudy record history shows Revision: v3.4.3, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page history shows a minor revision from v3.4.1 to v3.4.2; no content or functionality changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe history shows Revision v3.4.1 replacing v3.4.0, a metadata update that does not affect study details or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedAdds a glossary toggle and color-coded change highlights on the history page, with minor wording and revision note updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check62 days agoChange DetectedThe history confirms an administrative update adding revision v3.3.4 and referencing v3.3.3 without any substantive changes to study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedNew site revision entry 'Revision: v3.3.3' was added to the history and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed from the footer; these are maintenance updates that do not affect the study content.SummaryDifference0.2%

Stay in the know with updates to AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.